Borgman Anne Elizabeth — SEC Form 4 filings
SEC reporting owner CIK 1886388. 11 Form 4 filings on record with FilingPulse; latest filed 2026-07-09.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-03-04 to 2026-07-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SUTRO BIOPHARMA, INC. (STRO) | CHIEF MEDICAL OFFICER | 4 | — | — | 16 |
| CURIS INC (CRIS) | Director | 4 | — | — | 4 |
| NextCure, Inc. (NXTC) | Director | 3 | — | — | 3 |
Form 4 filings — Borgman Anne Elizabeth
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-09 | 4 | CURIS INC (CRIS) | Grant/award (A): 6,800 (derivative) @ $5.29 | EDGAR |
| 2026-06-22 | 4 | NextCure, Inc. (NXTC) | Grant/award (A): 2,340 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | NextCure, Inc. (NXTC) | Grant/award (A): 18,700 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | CURIS INC (CRIS) | Grant/award (A): 14,400 (derivative) @ $3.13 | EDGAR |
| 2025-05-05 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 53,125 @ $0 · Option exercise (M): 15,938 @ $0 · Tax withholding (F): 24,709 @ $1.07 · Option exercise (M): 53,125 (derivative) @ $0 · Option exercise (M): 15,938 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 37,500 @ $0 · Tax withholding (F): 15,405 @ $1.59 · Option exercise (M): 11,250 @ $0 · Tax withholding (F): 4,621 @ $1.59 · Option exercise (M): 37,500 (derivative) @ $0 · Option exercise (M): 11,250 (derivative) @ $0 | EDGAR |
| 2025-01-30 | 4 | CURIS INC (CRIS) | Grant/award (A): 1,600 (derivative) @ $3.13 | EDGAR |
| 2024-06-21 | 4 | NextCure, Inc. (NXTC) | Grant/award (A): 18,700 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | CURIS INC (CRIS) | Grant/award (A): 4,250 (derivative) @ $11.62 | EDGAR |
| 2024-03-07 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Grant/award (A): 60,000 (derivative) @ $0 · Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Option exercise (M): 37,500 @ $0 · Tax withholding (F): 13,126 @ $4.91 · Option exercise (M): 37,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1886388 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →